Literature DB >> 15676152

Molecular and cytogenetic characterization of a novel rearrangement involving chromosomes 9, 12, and 17 resulting in ETV6 (TEL) and ABL fusion.

C A Tirado1, S Sebastian, J O Moore, J Z Gong, B K Goodman.   

Abstract

We performed chromosome analysis on the bone marrow of a patient with BCR/ABL negative chronic myelogenous leukemia (CML). By interphase fluorescence in situ hybridization (FISH), an extra ABL signal was present in interphase nuclei and appeared to be located at 17p in the metaphase cells. Chromosome analysis showed a subtle abnormality at 17p13 and 12p13 but no visible rearrangement at 9q34 (ABL). Additional FISH experiments disclosed a rearrangement between the short arms of chromosomes 12 and 17 at approximately bands 12p13 and 17p13, respectively. In addition, subtelomeric FISH analysis confirmed the presence of terminal 12p at 17p13 and showed terminal 9q34 to be intact on each chromosome 9. Taken together, these results indicated a rearrangement involving chromosomes 9, 12, and 17 that suggested the possibility of juxtaposition of part of the ETV6 (also known as TEL) locus (12p13) with a portion of ABL (9q34) together at 17p13. The ETV6/ABL fusion was confirmed by RT-PCR, which showed that the first 5 exons of ETV6 were fused in frame with ABL at exon 2. Wild-type ETV6 and ABL were also expressed, in accordance with the FISH results that showed no loss of the second ETV6 or ABL allele.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15676152     DOI: 10.1016/j.cancergencyto.2004.06.001

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  ETV6-ABL1-positive "chronic myeloid leukemia": clinical and molecular response to tyrosine kinase inhibition.

Authors:  Fabiana Perna; Omar Abdel-Wahab; Ross L Levine; Suresh C Jhanwar; Kazunori Imada; Stephen D Nimer
Journal:  Haematologica       Date:  2010-12-29       Impact factor: 9.941

2.  Characterization of leukemias with ETV6-ABL1 fusion.

Authors:  Marketa Zaliova; Anthony V Moorman; Giovanni Cazzaniga; Martin Stanulla; Richard C Harvey; Kathryn G Roberts; Sue L Heatley; Mignon L Loh; Marina Konopleva; I-Ming Chen; Olga Zimmermannova; Claire Schwab; Owen Smith; Marie-Joelle Mozziconacci; Christian Chabannon; Myungshin Kim; J H Frederik Falkenburg; Alice Norton; Karen Marshall; Oskar A Haas; Julia Starkova; Jan Stuchly; Stephen P Hunger; Deborah White; Charles G Mullighan; Cheryl L Willman; Jan Stary; Jan Trka; Jan Zuna
Journal:  Haematologica       Date:  2016-05-26       Impact factor: 9.941

3.  Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review.

Authors:  Katya Gancheva; Andres Virchis; Julie Howard-Reeves; Nick Cp Cross; Diana Brazma; Colin Grace; Paul Kotzampaltiris; Fedra Partheniou; Elisabeth Nacheva
Journal:  Mol Cytogenet       Date:  2013-09-20       Impact factor: 2.009

4.  An ETV6-ABL1 fusion in a patient with chronic myeloproliferative neoplasm: Initial response to Imatinib followed by rapid transformation into ALL.

Authors:  Purvi M Kakadia; Ralf Schmidmaier; Andreas Völkl; Irene Schneider; Natalia Huk; Stephanie Schneider; Gerda Panzner; Ulrike Neidel; Barbara Fritz; Karsten Spiekermann; Stefan K Bohlander
Journal:  Leuk Res Rep       Date:  2016-10-14

5.  An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia.

Authors:  O Zimmermannova; E Doktorova; J Stuchly; V Kanderova; D Kuzilkova; H Strnad; J Starkova; M Alberich-Jorda; J H F Falkenburg; J Trka; J Petrak; J Zuna; M Zaliova
Journal:  Oncogene       Date:  2017-06-26       Impact factor: 9.867

6.  A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature.

Authors:  Carlos A Tirado; Ken Siangchin; David S Shabsovich; Maryam Sharifian; Gary Schiller
Journal:  Biomark Res       Date:  2016-08-25

7.  [Acute myeloid leukemia with co-expression of TEL-ABL1 and NUP98-HOXA9 fusion genes: a case report and literature review].

Authors:  C Y Wu; Y L Li; X Y Dong; L Zhang; B J Shang; W Li; Z B Li; L Zhang; Z M Zhu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-07-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.